Identifying strategies to target the metabolic flexibility of tumours

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Nature Metabolism

• Publication date

  2020-01-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/s42255-020-0195-8PMID 32694609PMCID PMC7436715
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization

  2019cited by this paper
• Cellular redox state constrains serine synthesis and nucleotide production to impact cell proliferation

  2019cited by this paper
• Discovery of a Thiadiazole-Pyridazine Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models.

  2019cited by this paper
• Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes

  2019cited by this paper
• Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs.

  2019cited by this paper
• Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting.

  2019cited by this paper
• Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin

  2018cited by this paper
• Patient-derived tumor organoids for prediction of cancer treatment response.

  2018cited by this paper
• The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.

  2018cited by this paper
• Serine Availability Influences Mitochondrial Dynamics and Function through Lipid Metabolism

  2018cited by this paper
• Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trial

  2018cited by this paper
• Understanding the Intersections between Metabolism and Cancer Biology.

  2017cited by this paper
• Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

  2017cited by this paper
• Targeted Inhibition of EGFR and Glutaminase Induces Metabolic Crisis in EGFR Mutant Lung Cancer.

  2017cited by this paper
• Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass

  2017cited by this paper
• Hopefully devoted to Q: targeting glutamine addiction in cancer

  2017cited by this paper
• Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC

  2017cited by this paper
• Metabolic Interactions in the Tumor Microenvironment.

  2017cited by this paper
• Targeting Metabolism for Cancer Therapy.

  2017cited by this paper
• Modulating the therapeutic response of tumours to dietary serine and glycine starvation

  2017cited by this paper
• Drugging the 'undruggable' cancer targets

  2017cited by this paper
• The Emerging Hallmarks of Cancer Metabolism.

  2016cited by this paper
• Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma.

  2016cited by this paper
• Inhibition of acetyl-CoA carboxylase suppresses fatty acid synthesis and tumor growth of non-small cell lung cancer in preclinical models

  2016cited by this paper
• Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.

  2016cited by this paper
• Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer.

  2016cited by this paper
• Targeting metastasis-initiating cells through the fatty acid receptor CD36

  2016cited by this paper
• A PHGDH inhibitor reveals coordination of serine synthesis and 1-carbon unit fate

  2016cited by this paper
• Genetic Pharmacotherapy as an Early CNS Drug Development Strategy: Testing Glutaminase Inhibition for Schizophrenia Treatment in Adult Mice

  2016cited by this paper
• Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers

  2016cited by this paper
• The importance of serine metabolism in cancer

  2016cited by this paper
• Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans

  2016cited by this paper
• Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.

  2016cited by this paper
• Distinct anti-oncogenic effect of various microRNAs in different mouse models of liver cancer

  2015cited by this paper
• Abstract CT203: Report of a first-in-human study of the first-in-class fatty acid synthase (FASN) inhibitor TVB-2640

  2015cited by this paper
• MYC, Metabolism, and Cancer.

  2015cited by this paper
• l-Serine Deficiency Elicits Intracellular Accumulation of Cytotoxic Deoxysphingolipids and Lipid Body Formation*

  2015cited by this paper
• Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis.

  2015cited by this paper
• Metabolic Flux Analysis

  2014cited by this paper
• Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells.

  2014cited by this paper
• Activation of Cre Recombinase Alone Can Induce Complete Tumor Regression

  2014cited by this paper
• Serine deprivation enhances antineoplastic activity of biguanides.

  2014cited by this paper
• An Artifact in LC-MS/MS Measurement of Glutamine and Glutamic Acid: In-Source Cyclization to Pyroglutamic Acid

  2014cited by this paper
• Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA)

  2014cited by this paper
• Hydrodynamic transfection for generation of novel mouse models for liver cancer research.

  2014cited by this paper
• Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport.

  2014cited by this paper
• Glutamine and cancer: cell biology, physiology, and clinical opportunities.

  2013cited by this paper
• Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors.

  2013cited by this paper
• In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture

  2013cited by this paper
• Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.

  2013cited by this paper
• Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Inositol Polyphosphate Multikinase Is a Coactivator of p53-Mediated Transcription and Cell Death

  2013cited by this paper
• Oncogene‐specific formation of chemoresistant murine hepatic cancer stem cells

  2012cited by this paper
• Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo.

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• c-Myc and Cancer Metabolism

  2012cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.

  2011cited by this paper
• Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration.

  2011cited by this paper
• Pyruvate carboxylase is required for glutamine-independent growth of tumor cells

  2011cited by this paper
• Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche

  2009cited by this paper
• rNMR: open source software for identifying and quantifying metabolites in NMR spectra

  2009cited by this paper
• 13C-based metabolic flux analysis

  2009cited by this paper
• Cancer cell metabolism: Warburg and beyond.

  2008cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.

  2005cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse

  2004cited by this paper
• Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

  2001cited by this paper
• Enzymes utilizing glutamine as an amide donor.

  1998cited by this paper
• Metabolism and Cancer

  1971cited by this paper
• Cáncer

  1939cited by this paper

• Glucose deprivation drives LIF-dependent lung cancer

  2026cites this paper
• ΔNp63α drives serine synthesis to promote carboplatin resistance in NSCLC

  2026cites this paper
• Amino acids metabolism: a potential target for cancer treatment

  2025cites this paper
• Digital twins for in vivo metabolic flux estimations in patients with brain cancer.

  2025cites this paper
• DNGR-1 signalling limits dendritic cell activation for optimal antigen cross-presentation

  2025cites this paper
• Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects

  2025cites this paper
• The cancer-induced lactate load and oncologic remodeling hypothesis: lactate as a driver of biosynthesis and epigenetics in cancer

  2025cites this paper
• Overview of glutamine metabolism in stromal components of the tumor microenvironment and potential anti-tumor therapies

  2025cites this paper
• Glutaminase 1 inhibitors: Therapeutic potential, mechanisms of action, and clinical perspectives.

  2025cites this paper
• Species-specific serine metabolism differentially controls natural killer cell functions

  2025cites this paper
• Oncogenic RBM19 modulated by MAX-mediated allelic transcription regulation in hepatocellular carcinoma progression.

  2025cites this paper
• Mitochondrial glutamine import sustains electron transport chain integrity independently of glutaminolysis in cancer.

  2025cites this paper
• TGF-β Coordinates Alanine Synthesis and Import for Myofibroblast Differentiation in Pulmonary Fibrosis

  2025cites this paper
• Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer

  2025cites this paper
• Research advances on amino acid starvation interventions for hepatocellular carcinoma.

  2025cites this paper
• Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells

  2025cites this paper
• The Landscape of Cancer Metabolism as a Therapeutic Target

  2025cites this paper
• Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AML

  2025cites this paper
• Metabolic Pathway Analysis of Tumors Using Stable Isotopes.

  2025cites this paper
• Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents.

  2025cites this paper
• Glutaminase‐1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells

  2025cites this paper
• Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

  2025cites this paper
• USP3 promotes clear cell renal cell carcinoma progression by stabilizing MYC and enhancing glycolysis.

  2025cites this paper
• Hafnium Metal-Organic Framework-Based Glutamine Metabolism Disruptor For Potentiating Radio-Immunotherapy in MYC-Amplified Hepatocellular Carcinoma.

  2025cites this paper
• A Multimodal Imaging Pipeline to Decipher Cell-Specific Metabolic Functions and Tissue Microenvironment Dynamics

  2025cites this paper
• AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis

  2024cites this paper
• Targeting Metabolic Adaptation of Colorectal Cancer with Vanadium‐Doped Nanosystem to Enhance Chemotherapy and Immunotherapy

  2024cites this paper
• Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions

  2024cites this paper
• A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer

  2024cites this paper
• A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer

  2024cites this paper
• Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib‐Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency

  2024cites this paper
• A CIA strategy with eminent drug-loading capacities for tumor ferroptosis-gas synergistic therapy

  2024cites this paper
• Targeting metabolic pathway enhance CAR-T potency for solid tumor.

  2024cites this paper
• Catabolism of extracellular glutathione supplies amino acids to support tumor growth

  2024cites this paper
• Targeting amino acid-metabolizing enzymes for cancer immunotherapy

  2024cites this paper
• A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer.

  2024cites this paper
• Defining neuroblastoma: From origin to precision medicine

  2024cites this paper
• High‐Lactate‐Metabolizing Photosynthetic Bacteria Reprogram Tumor Immune Microenvironment

  2024cites this paper
• One-carbon metabolism shapes T cell immunity in cancer.

  2024cites this paper
• Stable Isotope Tracing Analysis in Cancer Research: Advancements and Challenges in Identifying Dysregulated Cancer Metabolism and Treatment Strategies

  2024influential citation
• IFRD1 promotes tumor cells “low-cost” survival under glutamine starvation via inhibiting histone H1.0 nucleophagy

  2024cites this paper
• Mitochondrial calcium overload contributes to cannabinoid‐induced paraptosis in hormone‐responsive breast cancer cells

  2024cites this paper
• Cycling back to folate metabolism in cancer

  2024cites this paper
• Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma

  2024cites this paper
• Isotope-Selective Gas Sensing Using Photoacoustic Non-Dispersive Spectroscopy

  2024cites this paper
• DIMet: an open-source tool for differential analysis of targeted isotope-labeled metabolomics data

  2024cites this paper
• A computational discovery of hexokinase 2 inhibitors from Newbouldia laevis for Hepatocellular carcinoma (HCC) treatment

  2024cites this paper
• Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma

  2024cites this paper
• Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology

  2023cites this paper
• Identifying targetable metabolic dependencies across colorectal cancer progression

  2023cites this paper
• Systematic diet composition swap in a mouse genome-scale metabolic model reveals determinants of obesogenic diet metabolism in liver cancer

  2023cites this paper
• Filament formation drives catalysis by glutaminase enzymes important in cancer progression

  2023cites this paper
• PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma

  2023cites this paper
• Impairing Tumor Metabolic Plasticity via a Stable Metal‐Phenolic‐Based Polymeric Nanomedicine to Suppress Colorectal Cancer

  2023cites this paper
• Targeting glutamine metabolism as a therapeutic strategy for cancer

  2023cites this paper
• Succinate-Directed Approaches for Warburg Effect-Targeted Cancer Management, an Alternative to Current Treatments?

  2023cites this paper
• Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers

  2023cites this paper
• Salvianolic acid A diminishes LDHA‐driven aerobic glycolysis to restrain myofibroblasts activation and cardiac fibrosis via blocking Akt/GSK‐3β/HIF‐1α axis

  2023cites this paper
• A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer

  2023cites this paper
• Dietary Manipulation of Amino Acids for Cancer Therapy

  2023cites this paper
• Cancer Metabolism Historical Perspectives: A Chronicle of Controversies and Consensus.

  2023cites this paper
• Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer

  2023cites this paper
• Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

  2023cites this paper
• Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• MYC disrupts transcriptional and metabolic circadian oscillations in cancer and promotes enhanced biosynthesis

  2023cites this paper
• Metabolic pathway analysis using stable isotopes in patients with cancer

  2023cites this paper
• Vitamin B5 supports MYC oncogenic metabolism and tumor progression in breast cancer

  2023influential citation
• Metabolic Heterogeneity of Tumors

  2023cites this paper
• Phenotypic profiling of solute carriers characterizes serine transport in cancer

  2023cites this paper
• Glutaminase inhibition as potential cancer therapeutics: current status and future applications

  2023cites this paper
• Tumor Metabolic Heterogeneity

  2023cites this paper
• Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies

  2022cites this paper
• Branched-chain amino acid catabolism breaks glutamine addiction to sustain hepatocellular carcinoma progression.

  2022cites this paper
• In vivo characterization of glutamine metabolism identifies therapeutic targets in clear cell renal cell carcinoma

  2022cites this paper
• Genome‐Wide CRISPR/Cas9 Library Screening Revealed Dietary Restriction of Glutamine in Combination with Inhibition of Pyruvate Metabolism as Effective Liver Cancer Treatment

  2022cites this paper
• Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins.

  2022cites this paper
• Modifying dietary amino acids in cancer patients.

  2022cites this paper
• In vivo Deuterium Magnetic Resonance Spectroscopy reveals Glucose fluxes through glycolysis and mitochondrial oxidation pathways in mouse Glioblastoma

  2022cites this paper
• Combination strategies to target metabolic flexibility in cancer.

  2022cites this paper
• Publisher Correction: MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine

  2022influential citation
• MYC sensitises cells to apoptosis by driving energetic demand

  2022cites this paper
• GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors.

  2022cites this paper
• [18F]-(2S,4R)4-Fluoroglutamine PET Imaging of Glutamine Metabolism in Murine Models of Hepatocellular Carcinoma (HCC)

  2022cites this paper
• Glutamine addiction promotes glucose oxidation in triple-negative breast cancer

  2022cites this paper
• Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

  2022cites this paper
• High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia

  2022cites this paper
• Novel MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine

  2022cites this paper
• Oncogenic metabolic rewiring independent of proliferative control in human mammary epithelial cells

  2022cites this paper
• Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells

  2022cites this paper
• Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition

  2022cites this paper
• Research Outputs

  2022cites this paper
• High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding

  2022cites this paper
• Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma

  2022cites this paper
• Tumor Microenvironment-Derived Metabolites: A Guide to Find New Metabolic Therapeutic Targets and Biomarkers

  2021cites this paper
• Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

  2021cites this paper
• Dinner is served, sir: Fighting cancer with the right diet.

  2021cites this paper
• Impact of cancer metabolism on therapy resistance - Clinical implications.

  2021cites this paper
• Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

  2021cites this paper
• Targeting cancer metabolism in the era of precision oncology

  2021cites this paper